Observations placeholder
Plaquenil
Identifier
015657
Type of Spiritual Experience
Background
A description of the experience
Hydroxychloroquine is an antimalarial drug, sold under the trade names Plaquenil, Axemal (in India), Dolquine and Quensyl, also used to reduce inflammation in the treatment of rheumatoid arthritis (see disease-modifying antirheumatic drugs) and lupus. Hydroxychloroquine differs from chloroquine by the presence of a hydroxyl group at the end of the side chain: The N-ethyl substituent is beta-hydroxylated. It is available for oral administration as hydroxychloroquine sulfate (plaquenil) of which 200 mg contains 155 mg base in chiral form. Hydroxychloroquine has similar pharmacokinetics to chloroquine, with quick gastrointestinal absorption and elimination by the kidney. Cytochrome P450 enzymes (CYP 2D6, 2C8, 3A4 and 3A5) metabolize hydroxychloroquine to N-desethylhydroxychloroquine.
It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system
On Dec, 27, 2016 26,525 people reported to have side effects when taking Plaquenil.
Among them, 49 people (0.18%) have Hallucination
Time on Plaquenil when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 0.00% | 25.00% | 25.00% | 25.00% | 25.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Plaquenil :
| Female | Male | |
| Hallucination | 94.87% | 5.13% |
Age of people who have Hallucination when taking Plaquenil :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 0.00% | 0.00% | 12.12% | 12.12% | 24.24% | 6.06% | 45.45% |